Literature DB >> 19660797

Risks, advantages, and complications of intercostal vs subcostal approach for percutaneous nephrolithotripsy.

Erich Lang1, Raju Thomas, Ronald Davis, Ivan Colon, Mohamad Allaf, Amer Hanano, Alexander Kagen, Erum Sethi, Kirsten Emery, Ernest Rudman, Leann Myers.   

Abstract

OBJECTIVES: To establish the efficacy of nephrolithotripsy via intercostal access route vs subcostal access route with respect to attained stone-free status, operating time, and complications.
METHODS: Percutaneous nephrolithotripsies via the upper pole were performed in 142 patients (93 male, 49 female, age 24-78 years) from 1998 to 2005 at our 4 academic medical centers. Selection criteria for nephrolithotripsy via upper pole access were staghorn calculi > or = 5.5 cm(3), upper pole calyx calculi > or = 2.5 cm, and abnormal or high lying kidney, often in combination with obesity. Of 68 staghorn calculi, 49 were accessed via intercostal and 19 via subcostal route. Of 57 upper calyx calculi 38 were accessed via intercostal and 19 via subcostal route; all calculi in the upper ureter considered easily accessible via the intercostal route.
RESULTS: Of 103 patients with intercostal access, 91 attained a stone-free status. There were 4 major and 6 minor complications. Depending on stone location, mean operating times varied from 42 to 152 minutes. Of 39 patients in whom a subcostal access route was chosen, 29 were made stone-free. There were 3 major and 8 minor complications. The mean operating time varied from 108 to 145 minutes.
CONCLUSIONS: The significantly higher rate of achieving stone-free status, lower rate of complications, and markedly reduced operating time when using intercostal access make this the route of choice for upper pole nephrolithotripsy.

Entities:  

Mesh:

Year:  2009        PMID: 19660797     DOI: 10.1016/j.urology.2009.04.087

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  8 in total

1.  Flank bulge following supracostal percutaneous nephrolithotomy: A report of 2 cases.

Authors:  Andrea G Lantz; Kenneth T Pace; R John D'A Honey
Journal:  Can Urol Assoc J       Date:  2013 Jul-Aug       Impact factor: 1.862

2.  Supracostal access for miniaturized percutaneous nephrolithotomy: comparison of supracostal and infracostal approaches.

Authors:  Faruk Ozgor; Abdulkadir Tepeler; Ismail Basibuyuk; Onur Kucuktopcu; Yunus Kayali; Fatih Yanaral; Murat Binbay
Journal:  Urolithiasis       Date:  2017-03-30       Impact factor: 3.436

Review 3.  Percutaneous nephrolithotomy: technique.

Authors:  Thomas Knoll; Francisco Daels; Janak Desai; Andras Hoznek; Bodo Knudsen; Emanuele Montanari; Cesare Scoffone; Andreas Skolarikos; Keiichi Tozawa
Journal:  World J Urol       Date:  2017-01-25       Impact factor: 4.226

4.  Hemothorax during miniaturized endoscopic combined intrarenal surgery under ureteroscope-assisted ultrasound-guided access.

Authors:  Yutaro Tanaka; Kazumi Taguchi; Shuzo Hamamoto; Yuya Ota; Risa Oda; Keisuke Yokota; Ryosuke Ando; Atsushi Okada; Keiichi Tozawa; Ryoichi Nakanishi; Takahiro Yasui
Journal:  IJU Case Rep       Date:  2019-06-09

5.  Image-Guided Access for Percutaneous Nephrolithotomy: A Single-Center Experience in 591 Patients.

Authors:  Patrick L Vande Lune; David Thayer; Naganathan Mani; Andrew Warren; Alana C Desai; Daniel J Picus; Andrew J Gunn
Journal:  Curr Urol       Date:  2019-07-20

6.  Retrograde upper-pole calyceal access for percutaneous nephrolithotripsy of stones in the lower-pole calyx.

Authors:  Khalid M Al-Otaibi
Journal:  Arab J Urol       Date:  2012-09-23

7.  A supracostal approach for percutaneous nephrolithotomy of staghorn calculi: A prospective study and review of previous reports.

Authors:  Tarek El-Karamany
Journal:  Arab J Urol       Date:  2012-09-28

8.  Rupture of ectopic renal arterial pseudoaneurysm after percutaneous nephrolithotomy.

Authors:  Mingshuai Wang; Junhui Zhang; Nianzeng Xing
Journal:  Int Braz J Urol       Date:  2016 Jul-Aug       Impact factor: 1.541

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.